Construction of a prokaryotic expression system of vacA gene and detection of vacA gene, VacA protein in Helicobacter pylori isolates and ant-VacA antibody in patients' sera

World Journal of Gastroenterology

Volumn 10, Issue 7, 2004, Pages 985-990

  Yan, Jie ^a   Mao, Ya Fei ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTISERUM; BACTERIAL ANTIGEN; CELL ANTIBODY; HELICOBACTER PYLORI VACCINE; METRONIDAZOLE; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; VACUOLATING TOXIN;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGENICITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE CONSTRUCT; GENE EXPRESSION SYSTEM; GENE INSERTION; GENE SEQUENCE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNITY; IMMUNODIFFUSION; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROKARYOSIS; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SEROLOGY; SEROPREVALENCE; WESTERN BLOTTING;

EID: 1842787506     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i7.985     Document Type: Article

References (61)

1. Ye GA, Zhang WD, Liu LM, Shi L, Xu ZM, Chen Y, Zhou DY. Helicobacter pylori vacA gene polymorphism and chronic gastrosis. Shijie Huaren Xiaohua Zazhi 2001; 9: 593-595
2. Lu SY, Pan XZ, Peng XW, Shi ZL. Effect of Hp infection on gastric epithelial cell kinetics in stomach diseases. Shijie Huaren Xiaohua Zazhi 1999; 7: 760-762
3. Zhang Z, Yuan Y, Gao H, Dong M, Wang L, Gong YH. Apoptosis, proliferation and p53 gene expression of H pylori associated gastric epithelial lesions. World J Gastroenterol 2001; 7: 779-782
4. Lu XL, Qian KD, Tang XQ, Zhu YL, Du Q. Detection of H pylori DNA in gastric epithelial cells by in situ hybridization. World J Gastroenterol 2002; 8: 305-307
5. Yao YL, Xu B, Song YG, Zhang WD. Overexpression of cyclin E in Mongolian gerbil with Helicobacter pylori-induced gastric precancerosis. World J Gastroenterol 2002; 8: 60-63
6. Guo DL, Dong M, Wang L, Sun LP, Yuan Y. Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H pylori-associated gastric diseases. World J Gastroenterol 2002; 8: 1009-1013
7. Peng ZS, Liang ZC, Liu MC, Ouyang NT. Studies on gastric epithelial cell proliferation and apoptosis in Hp associated gastric ulcer. Shijie Huaren Xiaohua Zazhi 1999; 7: 218-219
8. Hiyama T, Haruma K, Kitadai Y, Miyamoto M, Tanaka S, Yoshihara M, Sumii K, Shimamoto F, Kajiyama G. B-cell monoclonality in Helicobacter pylori-associated chronic atrophic gastritis. Virchows Arch 2001; 483: 232-237
9. Xia HHX. Association between Helicobacter pylori and gastric cancer: Current knowledge and future research. World J Gastroenterol 1998; 4: 93-96
10. Quan J, Fan XG. Progress in experimental research of Helicobacter pylori infection and gastric carcinoma. Shijie Huaren Xiaohua Zazhi 1999; 7: 1068-1069
11. Liu HF, Liu WW, Fang DC. Study of the relationship between apoptosis and proliferation in gastric carcinoma and its precancerous lesion. Shijie Huaren Xiaohua Zazhi 1999; 7: 649-651
12. Zhu ZH, Xia ZS, He SG. The effects of ATRA and 5-Fu on telomerase activity and cell growth of gastric cancer cells in vitro. Shijie Huaren Xiaohua Zazhi 2000; 8: 669-673
13. Tu SP, Zhong J, Tan JH, Jiang XH, Qiao MM, Wu YX, Jiang SH. Induction of apoptosis by arsenic trioxide and hydroxy camptothecin in gastric cancer cells in vitro. World J Gastroenterol 2000; 6: 532-539
14. Cai L, Yu SZ, Zhang ZF. Helicobacter pylori infection and risk of gastric cancer in Changle County, Fujian Province, China. World J Gastroenterol 2000; 6: 374-376
15. Yao XX, Yin L, Zhang JY, Bai WY, Li YM, Sun ZC. HTERT expression and cellular immunity in gastric cancer and precancerosis. Shijie Huaren Xiaohua Zazhi 2001; 9: 508-512
16. Xu AG, Li SG, Liu JH, Gan AH. Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. World J Gastroenterol 2001; 7: 403-406
17. Wang X, Lan M, Shi YQ, Lu J, Zhong YX, Wu HP, Zai HH, Ding J, Wu KC, Pan BR, Jin JP, Fan DM. Differential display of vincristine-resistance-related gene in gastric cancer SGC7901 cells. World J Gastroenterol 2002; 8: 54-59
18. Liu JR, Li BX, Chen BQ, Han XH, Xue YB, Yang YM, Zheng YM, Liu RH. Effect of cis-9, trans-11-conjugated linoleic acid on cell cycle of gastric adenocarcinoma cell line (SGC-7901). World J Gastroenterol 2002; 8: 224-229
19. Cai L, Yu SZ. A molecular epidemiologic study on gastric cancer in Changle, Fujian Province. Shijie Huaren Xiaohua Zazhi 1999; 7: 652-655
20. Gao GL, Yang Y, Yang SF, Ren CW. Relationship between proliferation of vascular andothelial cells and gastric cancer. Shijie Huaren Xiaohua Zazhi 2000; 8: 282-284
21. Xue XC, Fang GE, Hua JD. Gastric cancer and apoptosis. Shijie Huaren Xiaohua Zazhi 1999; 7: 359-361
22. Niu WX, Qin XY, Liu H, Wang CP. Clinicopathological analysis of patients with gastric cancer in 1200 cases. World J Gastroenterol 2001; 7: 281-284
23. Li XY, Wei PK. Diagnosis of stomach cancer by serum tumor markers. Shijie Huaren Xiaohua Zazhi 2001; 9: 568-570
24. Fang DC, Yang SM, Zhou XD, Wang DX, Luo YH. Telomere erosion is independent of microsatellite instability but related to loss of heterozygosity in gastric cancer. World J Gastroenterol 2001; 7: 522-526
25. Morgner A, Miehlke S, Stolte M, Neubauer A, Alpen B, Thiede C, Klann H, Hierlmeier FX, Ell C, Ehninger G, Bayerdörffer E. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori-associated gastric low-grade marginal zone B-cell lymphoma of MALT type. World J Gastroenterol 2001; 7: 248-253
26. Deng DJ. Progress of gastric cancer etiology: N-nitrosamides in the 1999s. World J Gastroenterol 2000; 6: 613-618
27. Liu ZM, Shou NH, Jiang XH. Expression of lung resistance protein in patients with gastric carcinoma and its clinical significance. World J Gastroenteral 2000; 6: 433-434
28. Guo CQ, Wang YP, Liu GY, Ma SW, Ding GY, Li JC. Study on Helicobacter pylori infection and p53, c-erbB-2 gene expression in carcinogenesis of gastric mucosa. Shijie Huaren Xiaohua Zazhi 1999; 7: 313-315
29. Cai L, Yu SZ, Ye WM, Yi YN. Fish sauce and gastric cancer: An ecological study in Fujian Province, China. World J Gastroenterol 2000; 6: 671-675
30. Xue FB, Xu YY, Wan Y, Pan BR, Ren J, Fan DM. Association of H pylori infection with gastric carcinoma: A Meta analysis. World J Gastroenterol 2001; 7: 801-804
31. Wang RT, Wang T, Chen K, Wang JY, Zhang JP, Lin SR, Zhu YM, Zhang WM, Cao YX, Zhu CW, Yu H, Cong YJ, Zheng S, Wu BQ. Helicobacter pylori infection and gastric cancer: Evidence from a retrospective cohort study and nested case-control study in China. World J Gastroenterol 2002; 8: 1103-1107
32. Hua JS. Effect of Hp: Cell proliferation and apoptosis on stomach cancer. Shijie Huaren Xiaohua Zazhi 1999; 7: 647-648
33. Liu DH, Zhang XY, Fan DM, Huang YX, Zhang JS, Huang WQ, Zhang YQ, Huang QS, Ma WY, Chai YB, Jin M. Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma. World J Gastroenterol 2001; 7: 500-505
34. Cao WX, Ou JM, Fei XF, Zhu ZG, Yin HR, Yan M, Lin YZ. Methionine-dependence and combination chemotherapy on human gastric cancer cells in vitro. World J Gastroenterol 2002; 8: 230-232
35. Michetti P, Kreiss C, Kotloff K, Porta N, Blanco JL, Bachmann D, Herranz M, Saldinger PF, Corthesy-Theulaz I, Losonsky G, Nichols R, Simon J, Stolte M, Ackerman S, Monath TP, Blum AL. Orla immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 1999; 116: 804-812
36. Suganuma M, Kurusu M, Okabe S, Sueoka N, Yoshida M, Wakatsuki Y, Fujiki H. Helicobacter pylori membrane protein 1: A new carcinogenic factor of Helicobacter pylori. Cancer Res 2001; 61: 6356-6359
37. Nakamura S, Matsumoto T, Suekane H, Takeshita M, Hizawa K, Kawasaki M, Yao T, Tsuneyoshi M, Iida M, Fujishima M. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut 2001; 48: 454-460
38. Uemura N, Okamoto S, Yamamoto S, Matsumura. N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789
39. Morgner A, Miehlke S, Fischbach W, Schmitt W, Muller-Hermelink H, Greiner A, Thiede C, Schetelig J, Neubauer A, Stolte M, Ehninger G, Bayerdorffer E. Complete remission of primary high-rade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 2001; 19: 2041-2048
40. Kate V, Ananthakrishnan N, Badrinath S. Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: Retrospective and prospective randomized controlled studies. Br J Surg 2001; 88: 1054-1058
41. Zhuang XQ, Lin SR. Progress in research on the relationship between Hp and stomach cancer. Shijie Huaren Xiaohua Zazhi 2000; 8: 206-207
42. Gao HJ, Yu LZ, Bai JF, Peng YS, Sun G, Zhao HL, Miu K, Lü XZ, Zhang XY, Zhao ZQ. Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions: H pylori infection, histological types and staging. World J Gastroenterol 2000; 6: 848-854
43. Yao YL, Zhang WD. Relation between Helicobacter pylori and gastric cancer. Shijie Huaren Xiaohua Zazhi 2001; 9: 1045-1049
44. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-17777
45. Harris PR, Cover TL, Crowe DR, Orenstein JM, Graham MF, Blaser MJ, Smith PD. Helicobacter pylori cytotoxin induces vacuolation of primary human mucosal epithelial cells. Infect Immun 1996; 64: 4867-4871
46. Pagliaccia C, de Bernard M, Lupetti P, Ji X, Burroni D, Cover TL, Papini E, Rappuoli R, Telford JL, Reyrat JM. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc Natl Acad Sci U S A 1998; 95: 10212-10217
47. Phadnis SH, Ilver D, Janzon L, Normark S, Westblom TU. Pathological significance and molecular characterization of the vocuolating toxin gene of Helicobacter pylori. Infect Immun 1994; 62: 1557-1565
48. Montecucco C, Papini E, de Bernard M, Zoratti M. Molecular and cellular activities of Helicobacter pylori pathogenic factors. FEBS Lett 1999; 452: 16-21
49. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 1996; 93: 14648-14653
50. Marchetti M, Arico B, Burroni D, Figura. N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267: 1655-1658
51. Prinz C, Hafsi N, Voland P. Helicobacter pylori virulence factors and the host immune response: Implications for therapeutic vaccination. Trends Microbiol 2003; 11: 134-138
52. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992; 267: 10570-10575
53. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, A Laboratory Manual [M]. 2nd edition. New York: Cold Spring Harbor Laboratory Press. 1989, pp1.21-1.52, 2.60-2.80, 7.3-7.35, 9.14-9.22
54. Ito Y, Azuma T, Ito S, Suto H, Miyaji H, Yamazaki Y, Kohli Y, Kuriyama M. Full-length sequence analysis of the vacA gene from cytotoxic and noncytotoxic Helicobacter pylori. J Infect Dis 1998; 178: 1391-1398
55. Strobel S, Bereswill S, Balig P, Allgaier P, Sonntag HG, Kist M. Identification and analysis of a new vacA genotype variant of Helicobacter pylori in different patient groups in Germany. J Clin Microbiol 1998; 36: 1285-1289
56. Chen Y, Wang JD, Shi L. In vitro study of the biological activities and immunogenicity of recombinant adhesion of Helicobacter pylori rHpaA. Zhonghua Yixue Zazhi 2001; 81: 276-279
57. McMahon BJ, Hennessy TW, Bensler JM, Bruden DL, Parkinson AJ, Morris JM, Reasonover AL, Hurlburt DA, Bruce MG, Sacco F, Butler JC. The relationship among previous antimicrobial use antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann Intern Med 2003; 139: 463-469
58. Wong WM, Gu Q, Wang WH, Fung FM, Berg DE, Lai KC, Xia HH, Hu WH, Chan CK, Chan AO, Yuen MF, Hui CK, Lam SK, Wong BC. Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance. Clin Infect Dis 2003; 37: 882-889
59. Chi CH, Lin CY, Sheu BS, Yang HB, Huang AH, Wu JJ. Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori. Aliment Pharmacol Ther 2003; 18: 347-353
60. Mao YF, Yan J, Li LW, Li SP. Construction of hpaA gene from a clinical isolate of Helicobacter pylori and identification of the fusion protein. World J Gastroenterol 2003; 9: 1529-1535
61. Kim N, Weeks DL, Shin JM, Scott DR, Young MK, Sachs G. Proteins released by Helicobacter pylori in vitro. J Bacteriol 2002; 184: 6155-6162